These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10100319)

  • 1. Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.
    Eliot LA; Foster RT; Jamali F
    Pharm Res; 1999 Feb; 16(2):309-13. PubMed ID: 10100319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hyperlipidemia on the pharmacokinetics, hepatic and pulmonary uptake of posaconazole in rat.
    Khalil HA; Elnaggar MM; Belal TS; El-Yazbi AF; Hamdy DA
    Eur J Pharm Sci; 2016 Aug; 91():190-5. PubMed ID: 27178487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of experimental hyperlipidemia on the pharmacokinetics of tadalafil in rats.
    Lee JH; Oh JH; Lee YJ
    J Pharm Pharm Sci; 2012; 15(4):528-37. PubMed ID: 23106956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
    Shayeganpour A; Jun AS; Brocks DR
    Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats.
    Choi JS; Choi I; Choi DH
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):231-8. PubMed ID: 25549928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
    Brocks DR; Ala S; Aliabadi HM
    Biopharm Drug Dispos; 2006 Jan; 27(1):7-16. PubMed ID: 16278928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats.
    Jardan YA; Brocks DR
    Biopharm Drug Dispos; 2016 Sep; 37(6):345-51. PubMed ID: 27194397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.
    Filgueira GCO; Filgueira OAS; Carvalho DM; Marques MP; Moisés ECD; Duarte G; Lanchote VL; Cavalli RC
    Br J Clin Pharmacol; 2017 Jul; 83(7):1571-1579. PubMed ID: 28042936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.
    Brocks DR; Wasan KM
    J Pharm Sci; 2002 Aug; 91(8):1817-26. PubMed ID: 12115809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of human immunodeficiency virus protease inhibitor, nelfinavir, in poloxamer 407-induced hyperlipidemic model rats.
    Sugioka N; Haraya K; Maeda Y; Fukushima K; Takada K
    Biol Pharm Bull; 2009 Feb; 32(2):269-75. PubMed ID: 19182388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea.
    Gabr RQ; El-Sherbeni AA; Ben-Eltriki M; El-Kadi AO; Brocks DR
    Can J Physiol Pharmacol; 2017 May; 95(5):530-538. PubMed ID: 28177686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of increased lipoproteins levels on the disposition of vincristine in rat.
    Khalil HA; Belal TS; El-Yazbi AF; Hamdy DA
    Lipids Health Dis; 2016 Sep; 15(1):152. PubMed ID: 27613245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The single dose poloxamer 407 model of hyperlipidemia; systemic effects on lipids assessed using pharmacokinetic methods, and its effects on adipokines.
    Chaudhary HR; Brocks DR
    J Pharm Pharm Sci; 2013; 16(1):65-73. PubMed ID: 23683606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grapefruit juice and orange juice effects on the bioavailability of nifedipine in the rat.
    Grundy JS; Eliot LA; Kulmatycki KM; Foster RT
    Biopharm Drug Dispos; 1998 Apr; 19(3):175-83. PubMed ID: 9570001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
    Balogh A; Gessinger S; Svarovsky U; Hippius M; Mellinger U; Klinger G; Hoffmann A; Oettel M
    Eur J Clin Pharmacol; 1998; 54(9-10):729-34. PubMed ID: 9923576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: induction of rat hepatic P-450 by grapefruit juice.
    Mohri K; Uesawa Y; Sagawa Ki
    Drug Metab Dispos; 2000 Apr; 28(4):482-6. PubMed ID: 10725318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.
    Dorababu M; Nishimura A; Prabha T; Naruhashi K; Sugioka N; Takada K; Shibata N
    Biomed Pharmacother; 2009 Nov; 63(9):697-702. PubMed ID: 19819100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.